Search

everythinglearnresearchcommunity

for

Search:↓

The new adapalene formulation using TyroSpheres is more effective and less irritating for acne treatment.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Methotrexate plus prednisolone had the fewest serious side effects.

Methotrexate caused a rare skin rash in a rheumatoid arthritis patient, which resolved after stopping the drug.

Certain drugs may cause vitiligo, so patients should be monitored.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

Combining soursop leaf extract with doxorubicin may improve breast cancer treatment and reduce side effects.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Objective assessment is needed to accurately determine medication use and adherence.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Starting 5-alpha reductase inhibitors does not significantly increase the risk of rhabdomyolysis in older men, but is linked to a higher risk of muscle conditions.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Dupilumab for atopic dermatitis can cause mild skin issues in some patients.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

The herbal combination of saw palmetto and stinging nettle reduces nighttime urination in men with urinary issues.